PVCRigid, unplasticized polyvinyl chloride (RPVC) — the low-cost, easy-forming push-through blister film that built pharmaceutical packaging. Clear and forgiving to form; poor barrier and under regulatory pressure.

PVC packaging: the low-cost, easy-forming blister standard under pressure

Rigid PVC — unplasticized polyvinyl chloride, often written RPVC — is the material that built the blister-packaging industry. Its combination of low cost, excellent clarity and exceptionally easy forming made it the default forming film for pharmaceutical and retail blisters for decades. It de-nests cleanly, die-cuts well, and forms into crisp cavities at modest temperatures with a forgiving process window, which is precisely why it became so entrenched. If a legacy blister line exists, it very probably runs PVC.

For pharmaceutical blisters specifically, PVC is used in its rigid, plasticizer-free form. That rigidity is functional, not incidental: it gives the blister structural integrity and, crucially, the push-through characteristic — the cavity is stiff enough that a tablet can be pressed out through the lidding foil with a thumb. The absence of plasticizer also removes one of the migration concerns associated with flexible PVC, making RPVC acceptable for direct contact in this application.

PVC's two real weaknesses are barrier and sustainability. Plain PVC is a poor barrier to both oxygen and moisture, so for moisture- or oxygen-sensitive drugs it must be coated or laminated — with PVDC, PCTFE (Aclar) or COC — to reach the required protection, adding cost and multi-material complexity. And PVC contains around 57% chlorine by weight, which drives environmental and regulatory concern; it is not a preferred recyclable mono-material, and it faces mounting pressure under REACH and the PPWR.

The result is a material in managed decline for new work, even as it remains widespread in existing lines. Where a project has no special barrier need and cost and forming ease dominate, PVC still makes a straightforward case. But for most new food and pharmaceutical development — especially in the EU and for export — the momentum has shifted decisively toward PET, PP and, for high-barrier drugs, aluminium cold-form. PVC's story now is less about capability than about regulatory and recyclability risk.

PVC grades and coated variants

RPVC (rigid, unplasticized PVC) is the standard blister-forming grade: rigid, plasticizer-free, clear, and easy to form. It provides the structural rigidity and push-through characteristic that pharmaceutical blisters rely on. On its own it is a poor barrier, suited to products that are not moisture- or oxygen-sensitive.

PVC/PVDC is RPVC coated with polyvinylidene chloride (PVDC) to add a moderate moisture and oxygen barrier. It is a common, cost-effective step up for moisture-sensitive tablets. PVDC itself faces chlorine-related environmental scrutiny, which tempers its long-term outlook.

PVC/PCTFE (Aclar) is RPVC laminated with PCTFE (Aclar), the highest-barrier plastic option for blisters, used for highly moisture-sensitive drugs. It delivers excellent moisture protection but at significantly higher cost, and the laminate is firmly multi-material; PCTFE is also a fluoropolymer (PFAS), which brings its own tightening regulatory scrutiny.

Medical-grade PVC uses formulations stabilised to meet ISO 10993 biocompatibility and ISO 11607 packaging standards, for sterile-barrier medical device blisters where PVC's rigidity and Tyvek compatibility are valued for protecting heavy or sharp devices.

PVC forming temperature and its forgiving window

PVC's great processing virtue is how easy and forgiving it is to form. As an amorphous polymer, it softens gradually as it heats rather than collapsing over a narrow range, giving it a wide, tolerant forming window — the opposite of semi-crystalline PP. Typical forming-surface temperatures sit around 130–150 °C, modest compared with PET, and the material draws crisply into cavities with good detail reproduction. On InnovaPax equipment, precut RPVC sheet is loaded, heated from the top, and formed with pressure from above plus vacuum from below; the process is comparatively unfussy.

That forgiving character is the whole reason PVC dominated blister packaging: lines run fast and stable, scrap is low, and the material de-nests and die-cuts cleanly. For high-speed pharmaceutical blistering, precise but achievable temperature control at the forming station is still important — even small deviations can cause micro-cracks or uneven walls in demanding cavity geometries — but the underlying window is far more tolerant than PP's, and the process is more robust than PET's.

The one hard boundary to respect is thermal degradation. PVC has a glass transition around 80 °C and forms well above it, but if overheated it begins to degrade and release hydrogen chloride, which is both a quality and an equipment-corrosion concern. Good practice keeps the material within its window and avoids prolonged dwell at high temperature. Within those limits, PVC is one of the most production-friendly forming films available.

Plug assist follows the usual logic: optional for shallow cavities thanks to the forgiving window, but recommended for medium cavities and required for deep draws to keep wall thickness even. Because PVC forms so readily, it tolerates deep and complex geometries well when properly plug-assisted, which is part of why it remained popular for intricate retail clamshells as well as pharmaceutical blisters.

A production note on foil sealing: PVC blister lines seal against push-through aluminium foil whose heat-seal lacquer is PVC-specific, and the seal window is comfortable — one reason validated lines run so stably. When lines convert to PET or PP, the foil's lacquer system must convert with them; treating the lidding foil as part of the material system, not an accessory, is what makes conversions succeed.

Where PVC persists: applications in depth

PVC's applications split cleanly along one line: pharmaceutical and medical blisters, where its push-through rigidity and validated forming behaviour keep legacy lines running, and cost-driven retail packaging, where its clarity and easy, detailed forming still compete. What changes across applications is how much the barrier and sustainability weaknesses matter.

Pharmaceutical blisters — The classic push-through tablet and capsule blister — RPVC's clarity and easy forming made it the industry standard. Medical device blisters — Rigid, puncture-resistant trays compatible with Tyvek lidding for sterile-barrier medical packaging. Retail clamshells — Low-cost transparent clamshells and blisters for consumer goods where barrier is not critical. Coated barrier blisters — PVC/PVDC or PVC/PCTFE laminates for moisture- and oxygen-sensitive drugs needing more protection.

In every case the same properties do the work: exceptional forming ease and clean de-nesting keep high-speed lines stable and low-scrap, rigidity delivers the push-through action pharmacopoeias and patients expect, and low sheet price anchors the cost case. Where the product is moisture- or oxygen-sensitive, PVC must be coated (PVDC, PCTFE) or ceded to aluminium cold-form; where mono-material recyclability or EU export rules bite, PET and PP take the ground. PVC's applications today are the ones its legacy infrastructure and cost still hold, not the ones it wins on merit for new work.

Specifying PVC: the decisions that matter

A responsible PVC specification today answers four questions explicitly. Is PVC actually required? — meaning a validated legacy line, a push-through requirement, or a cost case that survives the regulatory outlook; 'we have always used it' is precedent, not justification. Which rung of the barrier ladder? — plain RPVC, PVDC-coated, or Aclar-laminated, chosen against the drug's stability data rather than defensively over-specified.

Which foil system? — the lidding foil's heat-seal lacquer must be PVC-matched, and the push-through foil's rupture behaviour validated with the actual cavity geometry. And what is the exit plan? — tooling geometry drawn so a future PET or PP conversion inherits the footprint, and a validation dossier structured so requalification is an amendment rather than a restart.

Framed this way, PVC remains a legitimate, well-understood specification for the applications that genuinely need it — while the specification document itself carries the migration path that regulation will eventually demand. That dual character, present workhorse and planned legacy, is the honest way to write PVC into a new product in 2026.

Designing PVC blisters: push-through geometry and flanges

The defining design discipline for pharmaceutical PVC is push-through geometry. The cavity must be stiff enough that thumb pressure transfers to the tablet and ruptures the lidding foil, rather than dissipating into flexing plastic. That means matching cavity size closely to the product (excess headroom lets the tablet rattle and the cavity flex), keeping the dome shallow and rigid, and choosing gauge so the formed cavity resists deformation. A push-through blister that dents instead of dispensing is a geometry failure, not a foil failure.

Flange design carries the seal. Leave a flat, generous sealing land around each cavity — wide enough for the sealing tool with placement tolerance — and keep it planar: PVC forms so easily that flange distortion is rare, but any warp or draw-in at the flange edge becomes a leak path against the foil. For medical blisters sealed with Tyvek, the flange is also where peel initiation lives, so include a peel corner or tab in the outline.

PVC's easy, detailed forming invites feature-rich design — and it can deliver it. Crisp logos, alignment features, child-resistance geometries and intricate retail clamshell contours all form well in PVC at moderate temperatures. The material rewards designers who use that detail capability; radii can be tighter than in PP or PET without thinning penalties, though sensible radii still distribute stress in handling.

Denesting and trim: formed PVC webs die-cut cleanly and the parts de-nest well, one of the practical reasons the material has held high-speed lines. Design the trim line with adequate margin from cavity walls, and include denest features on deep retail clamshells so stacked parts release. PVC's clean die-cutting also permits tight, attractive outlines on retail blisters.

One material-level design decision sits above the geometry: plan the exit. Given PVC's regulatory trajectory, new blister designs are wisely drawn so the same tooling geometry can later run PET or PP with modest recipe changes — similar footprint, radii and draw ratios within what the successor material tolerates. Designing PVC parts that only PVC can form builds tomorrow's migration problem into today's tool.

PVC troubleshooting: degradation, cracks and seal failures

Yellowing, brown streaks or an acrid smell are PVC's most serious defect family: thermal degradation releasing hydrogen chloride. The causes are overheating or excessive dwell — a stalled sheet sitting under the heater is the classic trigger. Beyond scrap, HCl corrodes tooling and equipment, so degradation events deserve process attention, not just discarded parts. Fixes: verify heater setpoints and dwell, ensure line stoppages lift or shutter the heat, and purge degraded material fully before resuming.

Micro-cracks or crazing in formed cavities usually mean forming too cold: the sheet was drawn while insufficiently softened and took internal stress. In pharmaceutical blisters this is critical, because micro-cracks compromise the barrier and can propagate in handling. Raise the forming temperature toward the middle of PVC's window and confirm even heating; PVC's window is wide enough that there is rarely a reason to form at its cold edge.

Thin corners and floors in deep draws follow the universal rule: draw ratio exceeded what unassisted forming distributes. PVC's easy forming tempts deep, unassisted draws that then thin at the base. Add plug assist for medium and deep cavities and redistribute depth in the design where possible.

Plate-out and blooming — a hazy deposit building on tooling or the film surface — comes from formulation additives migrating under heat. It shows up as gradually degrading part gloss and dirty tools. Regular tool cleaning manages it; persistent plate-out is worth raising with the film supplier, as formulations differ meaningfully.

Seal failures against lidding foil are usually a lacquer-matching problem rather than a forming problem: the heat-seal lacquer on the foil must be specified for PVC (a PVC-lacquer foil will not bond properly to PET, and vice versa). If seals are weak despite correct temperature, pressure and dwell, confirm the foil's lacquer system matches the blister material before touching the process.

Sticking in the tool at ejection points to forming too hot or inadequate cooling before release — PVC releases well when formed within its window, so sticking is an early warning that temperatures have crept up toward the degradation zone. Treat it as a temperature symptom, not a release-agent problem.

PVC barrier: poor on its own, coated for pharma

The honest headline on PVC barrier is that plain RPVC is a poor barrier to both oxygen and moisture. For many retail and non-sensitive uses that is perfectly acceptable — the blister's job is physical protection and presentation, not shelf-life extension. But for moisture- or oxygen-sensitive pharmaceuticals, plain PVC is not enough on its own, and this is where most of PVC's barrier engineering happens.

The standard remedy is coating or lamination. PVC/PVDC adds a moderate moisture and oxygen barrier at modest cost and is the common first step for moisture-sensitive tablets. For highly moisture-sensitive drugs, PVC/PCTFE (Aclar) provides the best moisture protection available in a plastic blister, at a significant cost premium. COC coatings are also used. Each of these solves the barrier problem but at the price of turning a single material into a multi-material laminate — adding cost and, importantly, further weakening an already poor recyclability position.

This barrier-versus-recyclability tension is exactly why, for the most demanding moisture barriers, the industry increasingly bypasses PVC altogether in favour of aluminium cold-form blisters, which offer a near-absolute barrier without any plastic barrier layer. PVC's barrier story, in short, is one of a cheap and easy base material that must be built up with additional layers to meet serious protection needs — and those additions erode its cost and sustainability advantages.

PVC recyclability and regulatory pressure

PVC is the most regulatorily exposed of the common forming films, and its sustainability position is its greatest weakness. It contains around 57% chlorine by weight, which underlies persistent environmental concern, and it is not a preferred recyclable mono-material — it does not fit the clean recycling streams that PET and PP enjoy, and its presence can even contaminate other plastic recycling streams. On incineration it can release dioxins and hydrogen chloride, adding to the environmental case against it. Under the PPWR's grading of packaging by recyclability, and under broader REACH scrutiny, PVC sits on the wrong side of the trend.

The barrier coatings PVC often needs make this worse. PVC/PVDC and PVC/PCTFE laminates, added to reach pharmaceutical barrier requirements, convert the material into a multi-material structure that is harder still to recycle — and PVDC carries its own chlorine-related environmental scrutiny while PCTFE is a fluoropolymer under PFAS pressure. So the very step that makes PVC usable for sensitive drugs deepens its sustainability problem.

For these reasons, new packaging development — particularly in the EU and for export markets — increasingly designs PVC out, moving to PET and PP for general use and to aluminium cold-form for high-barrier pharmaceutical needs. PVC's rigid, unplasticized form remains functionally capable and is still widely used in existing lines, but its trajectory under tightening recyclability and chemical regulation is one of managed decline rather than growth. Where it is specified today, it is usually because an existing line, a cost target, or a specific push-through requirement makes it the pragmatic choice despite the regulatory headwind.

PVC vs PET vs PP for thermoformed packaging

PVC vs PET vs PP. PVC vs PET: PET is increasingly the preferred choice for new work. PVC is cheaper and easier to form, with a more forgiving window, and it de-nests and die-cuts beautifully — the reasons it dominated historically. But PET is recyclable as a mono-material, free of chlorine, UV-stable and meets the retailer and regulatory requirements PVC struggles with. For food and retail packaging especially, PET has largely displaced PVC; PVC now holds ground mainly in legacy pharmaceutical blister lines and cost-driven, barrier-insensitive retail applications. PVC vs PP: PP outperforms PVC on almost every technical axis that matters for food — a far better moisture barrier, heat resistance, recyclability and no chlorine. PVC's advantages are its lower cost, easier forming and superior clarity in thin gauges. PP has been steadily replacing PVC (and PS) in thin-walled food packaging on the strength of its properties and regulatory profile, leaving PVC's food role diminished. Where PVC still wins: PVC remains genuinely competitive in three situations — cost-driven applications where barrier is not critical, high-speed pharmaceutical blister lines already built around it (where its forming ease and push-through rigidity are valued and Tyvek compatibility supports medical use), and intricate clamshells that exploit its easy, detailed forming. Outside these, the combination of poor barrier, chlorine content and weak recyclability makes PVC a legacy choice rather than a first pick for new development. The forward-looking comparison is PVC vs its own coated variants vs cold-form: for any moisture-sensitive product, the real decision tree runs plain PVC to PVC/PVDC to PVC/Aclar to alu-alu cold-form, with barrier rising and cost, opacity and forming speed worsening at each step. Designers who frame the choice this way — as a barrier ladder priced against the drug's actual stability data — consistently avoid both under-protection and the expensive over-specification that plagues blister design.